ADC Therapeutics SA (ADCT) Stock Gains 1.11% This Week: Is It a Good Pick?

Friday, December 02, 2022 03:56 PM | InvestorsObserver Analysts

Mentioned in this article

ADC Therapeutics SA (ADCT) stock is down -83.81% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives ADCT stock a score of 34 out of a possible 100.

That rank is mainly influenced by a long-term technical score of 1. ADCT's rank also includes a short-term technical score of 6.
ADCT has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on ADCT!
See Full ADCT Report

What's Happening with ADCT Stock Today

ADC Therapeutics SA (ADCT) stock is higher by 4.61% while the S&P 500 is down -0.25% as of 3:56 PM on Friday, Dec 2. ADCT has gained $0.16 from the previous closing price of $3.47 on volume of 474,127 shares. Over the past year the S&P 500 has fallen -11.16% while ADCT is down -83.81%. ADCT lost -$2.15 per share in the over the last 12 months. Click Here to get the full Stock Report for ADC Therapeutics SA stock.

Share this article:

Related Articles